Patents by Inventor James J. Starling

James J. Starling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating resistant tumors
    Patent number: 6124311
    Abstract: The present invention provides methods for reversing multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene. This invention also provides methods for treating neoplasms in a mammal which comprises administering to a mammal in need of this treatment a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene in combination with an oncolytic agent.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: September 26, 2000
    Assignee: Eli Lilly and Company
    Inventors: Srinivasan Chandrasekhar, Anne H. Dantzig, Robert L. Shepard, James J. Starling, Mark A. Winter
  • Methods for reversing multidrug resistance
    Patent number: 6121292
    Abstract: The present invention provides methods for reversing multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene. This invention also provides methods for treating neoplasms in a mammal which comprises administering to a mammal in need of this treatment a substituted indole, benzofuran, benzothiophene, naphthalene, or dihydronaphthalene in combination with an oncolytic agent.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: September 19, 2000
    Assignee: Eli Lilly and Company
    Inventors: Srinivasan Chandrasekhar, Anne H. Dantzig, Robert L. Shepard, James J. Starling, Mark A. Winter
  • Method for treating resistant tumors
    Patent number: 5543428
    Abstract: This invention provides a method of reversing multidrug resistance in a multidrug resistance tumor comprising administering a multidrug resistance reversing amount of any of a series of phenoxy compounds as defined herein.
    Type: Grant
    Filed: August 31, 1994
    Date of Patent: August 6, 1996
    Assignee: Eli Lilly and Company
    Inventors: Jason S. Sawyer, Stephen M. Spaethe, James J. Starling
  • Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same
    Patent number: 5153118
    Abstract: Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens but not to prostate-specific antigen (PSA) or prostatic acid phosphatase (PAP); and methods of diagnosis and treatment employing the same.
    Type: Grant
    Filed: October 25, 1988
    Date of Patent: October 6, 1992
    Assignee: Eastern Virginia Medical Authority
    Inventors: George L. Wright, Jr., James J. Starling